Matches in Wikidata for { <http://www.wikidata.org/entity/Q65380870> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q65380870 description "clinical trial" @default.
- Q65380870 description "ensayu clínicu" @default.
- Q65380870 description "klinisch onderzoek" @default.
- Q65380870 description "клінічне випробування" @default.
- Q65380870 name "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 name "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 type Item @default.
- Q65380870 label "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 label "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 prefLabel "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 prefLabel "Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-risk Melanoma Patients" @default.
- Q65380870 P1050 Q65380870-017B94A9-029A-4E6B-84CF-71E6CF89468B @default.
- Q65380870 P1132 Q65380870-20DA849F-418B-4A88-A0FF-C41BC229B061 @default.
- Q65380870 P1476 Q65380870-8C0A9058-0EE6-444E-B4E2-52D756B60DFB @default.
- Q65380870 P17 Q65380870-7BAE8B99-1033-4980-BE92-D68CDB81E33F @default.
- Q65380870 P1813 Q65380870-DA893633-B921-4215-9B78-CD8F2C05A070 @default.
- Q65380870 P2899 Q65380870-EB4A0536-F1CC-4D8F-A02C-72FADAEB53B9 @default.
- Q65380870 P3098 Q65380870-FCE6EBB9-2465-4BC1-81AF-30494C48DAB7 @default.
- Q65380870 P31 Q65380870-7D1BF313-9081-4D90-A87D-91AFD0EE1428 @default.
- Q65380870 P580 Q65380870-6F38F983-83F2-4C6A-A83A-069F9CA33111 @default.
- Q65380870 P582 Q65380870-1F11B8EE-2D51-4514-9B08-D454A95C43DD @default.
- Q65380870 P6099 Q65380870-EEFD88EF-B2AD-40C5-A198-979E4D2AD76C @default.
- Q65380870 P8363 Q65380870-16F2C42F-FF26-43C9-9BCA-988967A3BF47 @default.
- Q65380870 P1050 Q180614 @default.
- Q65380870 P1132 "+160" @default.
- Q65380870 P1476 "Adjuvant Interleukin2 (Proleukin)and 5-(3,3 Dimethyl-1-Triazeno) Imidazole-4-Carboxamide (DTIC) in Resected High-Risk Primary and Regionally Metastatic Melanoma" @default.
- Q65380870 P17 Q30 @default.
- Q65380870 P1813 "DTIC" @default.
- Q65380870 P2899 "+18" @default.
- Q65380870 P3098 "NCT00553618" @default.
- Q65380870 P31 Q30612 @default.
- Q65380870 P580 "2007-08-01T00:00:00Z" @default.
- Q65380870 P582 "2022-08-01T00:00:00Z" @default.
- Q65380870 P6099 Q42824440 @default.
- Q65380870 P8363 Q78089383 @default.